Newsroom

Industry News

31 Mar

BioLineRx Prices $25 Million Underwritten Public Offering

TEL AVIV, Israel, March 31, 2017 /PRNewswire/ — BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical stage biopharmaceutical development company focused on oncology and immunology, today announced that it has priced an underwritten public offering of approximately 29.4 million American Depositary Shares (“ADSs”), each representing one (1) of its ordinary shares,...

Read more

30 Mar

Inovio and Collaborators Receive NIH Grant to Evaluate HIV Immunotherapy PENNVAX®-GP’s Ability to Induce Remission of HIV Infection and End Lifetime of Drug Therapy

PLYMOUTH MEETING, Pa., March 30, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (INO) announced today that its academic and industry collaborators received a multi-year $6.95 million grant from the NIH’s National Institute of Allergy and Infectious Diseases to develop a single or combination therapy using Inovio’s PENNVAX-GP with the...

Read more

30 Mar

CymaBay Therapeutics to Present at Two Investor Conferences in April

NEWARK, Calif., March 30, 2017 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company developing therapies for specialty and orphan diseases with high unmet medical need, today announced that management will provide a corporate overview at the H.C. Wainwright & Co. 1st Annual NASH Investor Conference, being...

Read more

29 Mar

Monster Digital Reiterates Action Camera and VR Strategy

SIMI VALLEY, CA–(Marketwired – Mar 29, 2017) – Monster Digital, Inc. ( NASDAQ : MSDI ) (“Monster Digital” or the “Company”), which develops, markets and distributes Monster branded products for use in high-performance consumer electronics, mobile products and computing applications, today reiterated its action camera and Virtual Reality strategy...

Read more

29 Mar

Youngevity Acquires BellaVita

SAN DIEGO, CA–(Marketwired – Mar 29, 2017) – Youngevity International, Inc. ( OTCQX : YGYI ), a leading omni-direct lifestyle company, today announced it has completed its acquisition of BellaVita, a producer of natural products based on the Mediterranean diet and lifestyle, including whole food beverages, essential oils and...

Read more

28 Mar

Asterias Biotherapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Highlights Recent Development Progress

FREMONT, Calif., March 28, 2017 /PRNewswire/ — Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company pioneering the field of regenerative medicine, today reported financial and operational results for the fourth quarter and year ended December 31, 2016 as well as  recent corporate progress. “Asterias has achieved substantial progress over...

Read more

Page 5 of 227« First...34567...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address